Bristol-Myers Squibb
BMY
#189
Rank
C$152.86 B
Marketcap
C$75.09
Share price
1.42%
Change (1 day)
-12.84%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): C$4.17

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$4.05. In 2024 the company made an earnings per share (EPS) of C-$6.03 a decrease over its 2023 EPS that were of C$5.29.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$4.17-169.22%
2024C-$6.03-213.92%
2023C$5.2930.2%
2022C$4.06-6.04%
2021C$4.33-179.29%
2020C-$5.46-281.37%
2019C$3.01-27.21%
2018C$4.13
2016C$3.64175.26%
2015C$1.32-19.83%
2014C$1.65-22.44%
2013C$2.1334.48%
2012C$1.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$14.24 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.04 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$2.35-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.84-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$27.99 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$17.77 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.05 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$14.99 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.36 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$4.14 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK